From Collection to Injection
14th Nov 2006, 00:58 GMT
Filed under: Type 1, Type 2, Childhood, Adult Onset, Drugs, Research Research data published by the prestigious British Journal of Haematology demonstrates that a patient's own blood has the capacity to assist in the regeneration and repair of a multitude of damaged tissues. The article sited technology developments and the scientific rationale supporting that technology. A novel stem cell population, called Synergetic Cell Population has been discovered and cultured under conditions that mimic the natural body environment where they develop into different cell types, such as blood vessel cells, heart muscle cells and even nerves. The data is promising as it seems that circulating blood has a much wider healing capacity than had previously been thought. Researchers are only just starting to reveal the potential of the blood to generate various functioning cell types. Dr. Valentin Fulga, TheraVitae Ltd's CEO and co- author of the article, added that bringing these results to the scientific community through a peer-reviewed article, was a key step to TheraVitae's strategy of advancing scientific research into adult stem cells and their clinical applications. "We intend to make maximum efforts to offer new hope to patients suffering from diseases that are presently considered to be incurable. We are proud to have had this opportunity to publish our data in a distinguished journal such as the British Journal of Haematology," he said. TheraVitae is a private, multinational company focused on using stem cells from the patient's own blood in order to treat a variety of disorders, especially cardiovascular diseases. The company has already developed a proprietary stem cell technology 'VesCell[TM]' that is currently being used by hospitals in Thailand and Singapore to treat patients with heart disease. With advancements like this just around the corner, one only knows what kind of therapies will prevail from our very own blood supply. Who says familiarity breeds contempt? Familiarly breeds cures, if this one goes the mile! Read | Permalink | Email this | Linking Blogs | Comments
From Collection to Injection related news:
- Spectrum Pharmaceuticals to Receive $5 mln Milestone Payment From PAR Pharmaceutical for Sumatriptan Injection — Pharmaceuticals News from StratCenter.com
- Metal injection molding seminar — Jobwerx.com
- Spectrum Pharmaceuticals Announces Agreement With GlaxoSmithKline to Settle Imitrex(R) Injection Patent Litigation Spectrum Filed ANDA With Paragraph IV Certification for Sumatriptan Injection in October 2004 and Received Tentative Approval From the FDA in October 2006 — mysan.de - Lifestyle News
- Spectrum Pharmaceuticals Announces Agreement With GlaxoSmithKline to Settle Imitrex Injection Patent Litigation — Government/ Industry Regulation News from StratCenter.com
- Par Pharmaceutical Announces Agreement With GlaxoSmithKline to Settle Imitrex Injection Patent Litigation — Partnerships/ Joint Ventures News from StratCenter.com
- Cami's Collection Adds a Line of Loomwoven Backpacks to its Holiday Offerings — PR.com Press Releases
- Sugababes: Singles Collection! — MTV.de Pop-News
- Spectrum Pharmaceuticals to Receive $5 Million Milestone Payment From PAR Pharmaceutical for Sumatriptan Injection — RedOrbit News - Health
- Raleigh Begins Annual Leaf Collection — NBC 17 - Local News
- Damien Hirst is curating an exhibition from his private collection — Guardian Unlimited